Punit Dhillon is the founder of Skye Bioscience. Skye Bioscience has raised $107M in total funding. Backed by 5AM Ventures, Versant.
Punit Dhillon is the Chairman, President, and CEO of Skye Bioscience Inc., a Nasdaq-listed public pharmaceutical company that develops cannabinoid derivatives. He started Skye as the first employee and built it into a clinical-stage company with support from major life science investors. Dhillon is also an author and entrepreneur.
Full founder directory · Investor directory · Company funding database · Fundraising library